Application Nr Approved Date Route Status External Links
NDA050514 None Ophthalmic None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage: Natacyn ® (Natamycin Ophthalmic Suspension) 5% Is Indicated For The Treatment Of Fungal Blepharitis, Conjunctivitis, And Keratitis Caused By Susceptible Organisms Including Fusarium Solani Keratitis. As In Other Forms Of Suppurative Keratitis, Initial And Sustained Therapy Of Fungal Keratitis Should Be Determined By The Clinical Diagnosis, Laboratory Diagnosis By Smear And Culture Of Corneal Scrapings And Drug Response. Whenever Possible The In Vitro Activity Of Natamycin Against The Responsible Fungus Should Be Determined. The Effectiveness Of Natamycin As A Single Agent In Fungal Endophthalmitis Has Not Been Established.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Natamycin NATAMYCIN ZINC169289635

Comments